BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 283 filers reported holding BLUEBIRD BIO INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $268,000 | -12.1% | 1,920 | -1.2% | 0.00% | 0.0% |
Q1 2019 | $305,000 | +28.7% | 1,944 | +1.4% | 0.00% | 0.0% |
Q4 2018 | $237,000 | -1.2% | 1,917 | -5.4% | 0.00% | 0.0% |
Q3 2018 | $240,000 | -30.4% | 2,026 | +6.5% | 0.00% | 0.0% |
Q2 2018 | $345,000 | +16.9% | 1,903 | +10.1% | 0.00% | 0.0% |
Q1 2018 | $295,000 | -20.3% | 1,728 | -3.0% | 0.00% | 0.0% |
Q4 2017 | $370,000 | +52.9% | 1,782 | +4.3% | 0.00% | 0.0% |
Q3 2017 | $242,000 | – | 1,708 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |